Skip to main content
Log in

Decreased levels of apolipoprotein A-I in plasma of schizophrenic patients

  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Summary

This study aims to identify the effects of antipsychotics on plasma proteins, and on the proteins associated with schizophrenia. We applied proteomics technology to screen protein aberrations in Sprague-Dawley rats treated with antipsychotics and schizophrenic patients undergoing medication. ApoA-I was found significantly increased in the chlorpromazine-treated rats and decreased in the patients with treatment-resistant schizophrenia, which suggest that decreased levels of apoA-I might be associated with the pathology of schizophrenia and that chlorpromazine increases apoA-I levels as part of its therapeutic action.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

ApoA-I:

Apolipoprotein A-I

ApoA-IV:

Apolipoprotein A-IV

ApoE:

Apolipoprotein E

References

  • T Arinami T Hirano K Kobayashi Y Yamanouchi H Hamaguchi (1990) ArticleTitleAssignment of the apolipoprotein A-I gene to 11q23 based on RFLP in a case with a partial deletion of chromosome 11, del(11)(q23.3-qter) Hum Genet 85 39–40 Occurrence Handle1972696 Occurrence Handle10.1007/BF00276323 Occurrence Handle1:CAS:528:DyaK3MXhvVCgug%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • AS Bassett (1992) ArticleTitleChromosomal aberrations and schizophrenia. Autosomes Br J Psychiatry 161 323–334 Occurrence Handle1393302 Occurrence Handle1:STN:280:DyaK3s%2Fgs1OktQ%3D%3D Occurrence Handle10.1192/bjp.161.3.323

    Article  PubMed  CAS  Google Scholar 

  • FP Bell (1983) ArticleTitleEffect of chlorpromazine on lipid metabolism in aortas from cholesterol-fed rabbits and normal rats, in vitro: inhibition of sterol esterification and modification of phospholipid synthesis Exp Mol Pathol 38 336–345 Occurrence Handle6852207 Occurrence Handle10.1016/0014-4800(83)90073-4 Occurrence Handle1:CAS:528:DyaL3sXkvVagur0%3D

    Article  PubMed  CAS  Google Scholar 

  • FP Bell EV Hubert (1981) ArticleTitleMembrane-active agents. Effect of various anesthetics and chlorpromazine on arterial lipid metabolism Atherosclerosis 39 517–525 Occurrence Handle7259830 Occurrence Handle10.1016/0021-9150(81)90009-5 Occurrence Handle1:CAS:528:DyaL3MXkslegt7o%3D

    Article  PubMed  CAS  Google Scholar 

  • B Dean SM Laws E Hone K Taddei E Scarr EA Thomas C Harper C McClean C Masters N Lautenschlager SE Gandy RN Martins (2003) ArticleTitleIncreased levels of apolipoprotein E in the frontal cortex of subjects with schizophrenia Biol Psychiatry 54 616–622 Occurrence Handle13129656 Occurrence Handle10.1016/S0006-3223(03)00075-1 Occurrence Handle1:CAS:528:DC%2BD3sXnt1Gnsbw%3D

    Article  PubMed  CAS  Google Scholar 

  • O Demirhan D Tastemir (2003) ArticleTitleChromosome aberrations in a schizophrenia population Schizophr Res 65 1–7 Occurrence Handle14623367 Occurrence Handle10.1016/S0920-9964(02)00504-2

    Article  PubMed  Google Scholar 

  • A Digney D Keriakous E Scarr E Thomas B Dean (2005) ArticleTitleDifferential changes in apolipoprotein E in schizophrenia and bipolar I disorder Biol Psychiatry 57 711–715 Occurrence Handle15820227 Occurrence Handle10.1016/j.biopsych.2004.12.028 Occurrence Handle1:CAS:528:DC%2BD2MXjtV2jsbk%3D

    Article  PubMed  CAS  Google Scholar 

  • U Eder-Ischia C Ebenbichler WW Fleischhacker (2005) ArticleTitleOlanzapine-induced weight gain and disturbances of lipid and glucose metabolism Essent Psychopharmacol 6 112–117 Occurrence Handle15765795

    PubMed  Google Scholar 

  • JH Eubanks M Djabali L Selleri DK Grandy O Civelli DL McElligott GA Evans (1992) ArticleTitleStructure and linkage of the D2 dopamine receptor and neural cell adhesion molecule genes on human chromosome 11q23 Genomics 14 1010–1018 Occurrence Handle1478642 Occurrence Handle10.1016/S0888-7543(05)80124-7 Occurrence Handle1:CAS:528:DyaK3sXhvVCrtrk%3D

    Article  PubMed  CAS  Google Scholar 

  • HM Gurling G Kalsi J Brynjolfson T Sigmundsson R Sherrington BS Mankoo T Read P Murphy E Blaveri A McQuillin H Petursson D Curtis (2001) ArticleTitleGenomewide genetic linkage analysis confirms the presence of susceptibility loci for schizophrenia, on chromosomes 1q32.2, 5q33.2, and 8p21-22 and provides support for linkage to schizophrenia, on chromosomes 11q23.3-24 and 20q12.1-11.23 Am J Hum Genet 68 661–673 Occurrence Handle11179014 Occurrence Handle10.1086/318788 Occurrence Handle1:CAS:528:DC%2BD3MXit1alu7o%3D

    Article  PubMed  CAS  Google Scholar 

  • M Hokin-Neaverson (1980) ArticleTitleActions of chlorpromazine, haloperidol and pimozide on lipid metabolism in guinea pig brain slices Biochem Pharmacol 29 2697–2700 Occurrence Handle7426073 Occurrence Handle10.1016/0006-2952(80)90092-1 Occurrence Handle1:CAS:528:DyaL3MXktFWluw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • L Jiang K Lindpaintner HF Li NF Gu H Langen L He M Fountoulakis (2003) ArticleTitleProteomic analysis of the cerebrospinal fluid of patients with schizophrenia Amino Acids 25 49–57 Occurrence Handle12836058 Occurrence Handle1:CAS:528:DC%2BD3sXkvFymsrw%3D

    PubMed  CAS  Google Scholar 

  • AV Kartelishev GP Kolupaev VM Kliuzhev ND Lakosina NS Vernekina AA Chebotkov LS Suslov (2003) ArticleTitlePathology and chemical verification and detection of “risk group” of endogenous psychosis Voen Med Zh 324 60–64 Occurrence Handle12722515 Occurrence Handle1:STN:280:DC%2BD3s3gtFaksw%3D%3D

    PubMed  CAS  Google Scholar 

  • MM Khan VV Parikh SP Mahadik (2003) ArticleTitleAntipsychotic drugs differentially modulate apolipoprotein D in rat brain J Neurochem 86 1089–1100 Occurrence Handle12911617 Occurrence Handle1:CAS:528:DC%2BD3sXmvFait70%3D Occurrence Handle10.1046/j.1471-4159.2003.01866.x

    Article  PubMed  CAS  Google Scholar 

  • Y La C Wan H Zhu Y Yang Y Chen Y Pan B Ji G Feng L He (2006) ArticleTitleHippocampus protein profiling reveals aberration of malate dehydrogenase in chlorpromazine/clozapine treated rats Neurosci Lett 408 29–34 Occurrence Handle16989946 Occurrence Handle10.1016/j.neulet.2006.05.026 Occurrence Handle1:CAS:528:DC%2BD28XhtVajsrnE

    Article  PubMed  CAS  Google Scholar 

  • CM Lewis DF Levinson LH Wise LE DeLisi RE Straub I Hovatta NM Williams SG Schwab AE Pulver SV Faraone LM Brzustowicz CA Kaufmann DL Garver HM Gurling E Lindholm H Coon HW Moises W Byerley SH Shaw A Mesen R Sherrington FA O’Neill D Walsh KS Kendler J Ekelund T Paunio J Lonnqvist L Peltonen MC O’Donovan MJ Owen DB Wildenauer W Maier G Nestadt JL Blouin SE Antonarakis BJ Mowry JM Silverman RR Crowe CR Cloninger MT Tsuang D Malaspina JM Harkavy-Friedman DM Svrakic AS Bassett J Holcomb G Kalsi A McQuillin J Brynjolfson T Sigmundsson H Petursson E Jazin T Zoega T Helgason (2003) ArticleTitleGenome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia Am J Hum Genet 73 34–48 Occurrence Handle12802786 Occurrence Handle10.1086/376549 Occurrence Handle1:CAS:528:DC%2BD3sXlsVOitL8%3D

    Article  PubMed  CAS  Google Scholar 

  • W Liu G Breen J Zhang S Li N Gu G Feng S Bai T Shen A Yu H Xue D St Clair L He (2003) ArticleTitleAssociation of APOE gene with schizophrenia in Chinese: a possible risk factor in times of malnutrition Schizophr Res 62 225–230 Occurrence Handle12837518 Occurrence Handle10.1016/S0920-9964(02)00384-5

    Article  PubMed  Google Scholar 

  • SP Mahadik MM Khan DR Evans VV Parikh (2002) ArticleTitleElevated plasma level of apolipoprotein D in schizophrenia and its treatment and outcome Schizophr Res 58 55–62 Occurrence Handle12363390 Occurrence Handle10.1016/S0920-9964(01)00378-4

    Article  PubMed  Google Scholar 

  • QH Meng J Bergeron DL Sparks YL Marcel (1995) ArticleTitleRole of apolipoprotein A-I in cholesterol transfer between lipoproteins. Evidence for involvement of specific apoA-I domains J Biol Chem 270 8588–8596 Occurrence Handle7721760 Occurrence Handle10.1074/jbc.270.24.14383 Occurrence Handle1:STN:280:DyaK2M3jvVentA%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • G Michalak (2003) ArticleTitleLipid abnormalities in schizophrenia – current knowledge Psychiatr Pol 37 965–976 Occurrence Handle14727369

    PubMed  Google Scholar 

  • ML Mimmack M Ryan H Baba J Navarro-Ruiz S Iritani RL Faull PJ McKenna PB Jones H Arai M Starkey PC Emson S Bahn (2002) ArticleTitleGene expression analysis in schizophrenia: reproducible up-regulation of several members of the apolipoprotein L family located in a high-susceptibility locus for schizophrenia on chromosome 22 Proc Natl Acad Sci USA 99 4680–4685 Occurrence Handle11930015 Occurrence Handle10.1073/pnas.032069099 Occurrence Handle1:CAS:528:DC%2BD38XivFSgsrY%3D

    Article  PubMed  CAS  Google Scholar 

  • K Saari J Jokelainen J Veijola H Koponen PB Jones M Savolainen MR Jarvelin L Lauren M Isohanni S Lindeman (2004) ArticleTitleSerum lipids in schizophrenia and other functional psychoses: a general population northern Finland 1966 birth cohort survey Acta Psychiatr Scand 110 279–285 Occurrence Handle15352929 Occurrence Handle10.1111/j.1600-0447.2004.00358.x Occurrence Handle1:CAS:528:DC%2BD2cXptVOlsrg%3D

    Article  PubMed  CAS  Google Scholar 

  • J Sasaki G Kumagae T Sata M Kuramitsu K Arakawa (1984) ArticleTitleDecreased concentration of high density lipoprotein cholesterol in schizophrenic patients treated with phenothiazines Atherosclerosis 51 163–169 Occurrence Handle6146320 Occurrence Handle10.1016/0021-9150(84)90164-3 Occurrence Handle1:CAS:528:DyaL2cXktFOhsbY%3D

    Article  PubMed  CAS  Google Scholar 

  • F Schurhoff MO Krebs A Szoke JY Loze C Goldberger V Quignon J Tignol F Rouillon JL Laplanche M Leboyer (2003) ArticleTitleApolipoprotein E in schizophrenia: a French association study and meta-analysis Am J Med Genet B Neuropsychiatr Genet 119 18–23 Occurrence Handle12707932 Occurrence Handle10.1002/ajmg.b.20007

    Article  PubMed  Google Scholar 

  • RL Spitzer JB Williams M Gibbon MB First (1992) ArticleTitleThe Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description Arch Gen Psychiatry 49 624–629 Occurrence Handle1637252 Occurrence Handle1:STN:280:DyaK38zksVGjuw%3D%3D

    PubMed  CAS  Google Scholar 

  • EA Thomas B Dean G Pavey JG Sutcliffe (2001) ArticleTitleIncreased CNS levels of apolipoprotein D in schizophrenic and bipolar subjects: implications for the pathophysiology of psychiatric disorders Proc Natl Acad Sci USA 98 4066–4071 Occurrence Handle11274430 Occurrence Handle10.1073/pnas.071056198 Occurrence Handle1:CAS:528:DC%2BD3MXis1Kht74%3D

    Article  PubMed  CAS  Google Scholar 

  • EA Thomas B Dean E Scarr D Copolov JG Sutcliffe (2003a) ArticleTitleDifferences in neuroanatomical sites of apoD elevation discriminate between schizophrenia and bipolar disorder Mol Psychiatry 8 167–175 Occurrence Handle10.1038/sj.mp.4001223 Occurrence Handle1:CAS:528:DC%2BD3sXhsFWrsr4%3D

    Article  CAS  Google Scholar 

  • Thomas EA, George RC, Danielson PE, Nelson PA, Warren AJ, Lo D, Sutcliffe JG (2003b) Antipsychotic drug treatment alters expression of mRNAs encoding lipid metabolism-related proteins. Mol Psychiatry 8: 983–993, 950

    Google Scholar 

  • F Wen J Tan (2003) ArticleTitleEffects of phenothiazine drugs on serum levels of apolipoproteins and lipoproteins in schizophrenic subjects Acta Pharmacol Sin 24 1001–1005 Occurrence Handle14531942 Occurrence Handle1:CAS:528:DC%2BD3sXotFSlu7k%3D

    PubMed  CAS  Google Scholar 

  • VE Zhitlovskii GV Tananova SL Bushuev (1982) ArticleTitleClinico-biochemical correlates in adolescents with abnormal rates of psychophysical development Zh Nevropatol Psikhiatr Im S S Korsakova 82 95–100 Occurrence Handle7180312 Occurrence Handle1:STN:280:DyaL3s%2Fps1Wjuw%3D%3D

    PubMed  CAS  Google Scholar 

  • M Zink A Schmitt B May B Muller DF Braus FA Henn (2004) ArticleTitleDifferential effects of long-term treatment with clozapine or haloperidol on GABA transporter expression Pharmacopsychiatry 37 171–174 Occurrence Handle15467974 Occurrence Handle10.1055/s-2004-827173 Occurrence Handle1:CAS:528:DC%2BD2cXmslWkt7w%3D

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

First two authors contributed equally.

Rights and permissions

Reprints and permissions

About this article

Cite this article

La, Y., Wan, C., Zhu, H. et al. Decreased levels of apolipoprotein A-I in plasma of schizophrenic patients. J Neural Transm 114, 657–663 (2007). https://doi.org/10.1007/s00702-006-0607-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00702-006-0607-2

Navigation